VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions

被引：1
|
作者：
Yang, Yaning
Liu, Chengming
Yang, Guangjian
Xu, Haiyan
Lei, Siyu
Wang, Yan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
VEGFA; targeted therapy; resistance; EGFR exon 20 insertions; non-small cell lung cancer;
D O I：
10.1158/1538-7445.AM2024-3263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3263
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
    Cao, Peijun
    Li, Yongwen
    Shi, Ruifeng
    Yuan, Yin
    Gong, Hao
    Zhu, Guangsheng
    Zhang, Zihe
    Chen, Chen
    Zhang, Hongbing
    Liu, Minghui
    Pan, Zhenhua
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [22] Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
    Guo-Hao Xia
    Yun Zeng
    Ying Fang
    Shao-Rong Yu
    Li Wang
    Mei-Qi Shi
    Wei-Li Sun
    Xin-En Huang
    Jia Chen
    Ji- Feng Feng
    Cancer Biology & Medicine, 2014, 11 (04) : 270 - 276
  • [23] Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
    Ma, Shiqi
    Zhang, Lu
    Ren, Yuan
    Dai, Wei
    Chen, Tingqing
    Luo, Liping
    Zeng, Juan
    Mi, Kun
    Lang, Jinyi
    Cao, Bangrong
    ONCOGENE, 2021, 40 (14) : 2596 - 2609
  • [24] Inhitibing GRP78 in non-small cell lung cancer with acquired resistance to EGFR-TKI
    Park, Jaewoo
    Purushothaman, Baskaran
    Hong, Sera
    Choi, Munkyung
    Song, Joon Myong
    Kang, Keon Wook
    CANCER RESEARCH, 2023, 83 (07)
  • [25] Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung Cancer
    Osude, Chike
    Lin, Leo
    Patel, Meet
    Eckburg, Adam
    Berei, Joseph
    Kuckovic, Adijan
    Dube, Namrata
    Rastogi, Aayush
    Gautam, Shruti
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Puri, Neelu
    CELLS, 2022, 11 (10)
  • [26] NOTCH-1 CONTRIBUTES TO EGFR-TKI ACQUIRED RESISTANCE IN NON-SMALL CELL LUNG CANCER
    Xie, M.
    Zhang, L.
    Xu, F.
    RESPIROLOGY, 2012, 17 : 89 - 89
  • [27] Role of AKT3 in EGFR-TKI resistance of non-small cell lung cancer.
    Huang, Shih-Hsiang
    Shih, Jin-Yuan
    Chen, Ching-Chow
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 55 - 55
  • [28] Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
    Shiqi Ma
    Lu Zhang
    Yuan Ren
    Wei Dai
    Tingqing Chen
    Liping Luo
    Juan Zeng
    Kun Mi
    Jinyi Lang
    Bangrong Cao
    Oncogene, 2021, 40 : 2596 - 2609
  • [29] Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance
    Liu, Detian
    Lu, Xiaolin
    Huang, Wentao
    Zhuang, Wei
    FRONTIERS IN GENETICS, 2023, 14
  • [30] The reversible resistance mechanisms of second generation EGFR-TKI, Dacomitinib, in non-small cell lung cancer
    Haga, Yuya
    Tsutsumi, Yasuo
    CANCER SCIENCE, 2023, 114 : 1071 - 1071
12345